Two important new studies challenge the controversial hypothesis that venous congestion–chronic cerebrospinal venous insufficiency (CCSVI)–contributes to the development of multiple sclerosis (MS). This theory has resulted in many MS patients receiving experimental endovascular angioplasty, a treatment for MS unproven by clinical trials.